Can lay people deliver asthma self-management education as effectively as primary care based practice nurses?

Partridge, M. R.; Caress, A.-L.; Brown, C.; Hennings, J.; Luker, K.; Woodcock, A.; Campbell, M.
September 2008
Thorax;Sep2008, Vol. 63 Issue 9, p778
Academic Journal
Objectives: To determine whether well trained lay people could deliver asthma self-management education with comparable outcomes to that achieved by primary care based practice nurses. Design: Randomised equivalence trial. Setting: 39 general practices in West London and North West England. Participants: 567 patients with asthma who were on regular maintenance therapy. 15 lay educators were recruited and trained to deliver asthma self-management education. Intervention: An initial consultation of up to 45 mm offered either by a lay educator or a practice based primary care nurse, followed by a second shorter face to face consultation and telephone follow-up for 1 year. Main outcome measures: Unscheduled need for healthcare. Secondary outcome measures: Patient satisfaction and need for courses of oral steroids. Results: 567 patients were randomised to care by a nurse (n = 287) or a lay educator (n = 280) and 146 and 171, respectively, attended the first face to face educational session. During the first two consultations, management changes were made in 35/146 patients seen by a practice nurse (24.0%) and in 56/171 patients (32.7%) seen by a lay educator. For 418/567 patients (73.7%), we have 1 year data on use of unscheduled healthcare. Under an intention to treat approach, 61/205 patients (29.8%) in the nurse led group required unscheduled care compared with 65/213 (30.5%) in the lay led group (90% Cl for difference -8.1% to 6.6%; 95% CI for difference -9.5% to 8.0%). The 90% Cl contained the predetermined equivalence region (-5% to +5%) giving an inconclusive result regarding the equivalence of the two approaches. Despite the fact that all patients had been prescribed regular maintenance therapy, 122/418 patients (29.2%) required courses of steroid tablets during the course of 1 year. Patient satisfaction following the initial face to face consultation was similar in both groups. Conclusions: It is possible to recruit and train lay educators to deliver a discrete area of respiratory care, with comparable outcomes to those seen by nurses.


Related Articles

  • Using Clinical Measures of Disease Control to Reduce the Burden of Asthma. Bateman, E.D. // PharmacoEconomics;Oct2001 Supplement 2, Vol. 19 Issue 10, p7 

    Clinical treatment guidelines encourage physicians to select asthma treatment in order to achieve established clinical treatment goals. Treatment selected on this basis may have profound effects upon other outcomes, some of which, such as improvements in well-being and lifestyle, are of direct...

  • Using Humanistic Health Outcomes Data in Asthma. Juniper, E.F. // PharmacoEconomics;Oct2001 Supplement 2, Vol. 19 Issue 10, p13 

    One of the aims of treatment of asthma is to improve patient well-being, which incorporates the concept of patients' perceptions of how they feel and their ability to function in their everyday life [health-related quality of life (HR-QOL)]. The weak association between conventional measures of...

  • Comparison of Physician-, Biomarker-r and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults With Asthma. Calhoun, William J.; Ameredes, Bill T.; King, Tonya S.; Icitovic, Nikolina; Bleecker, Eugene R.; Castro, Mario; Cherniack, Reuben M.; Chinchilli, Vernon M.; Craig, Timothy; Denlinger, Loren; DiMango, Emily A.; Engle, Linda L.; Fahy, John V.; Grant, J. Andrew; Israel, Elliot; Jarjour, Nizar; Kazani, Shamsah D.; Kraft, Monica; Kunselman, Susan J.; Lazarus, Stephen C. // JAMA: Journal of the American Medical Association;9/12/2012, Vol. 308 Issue 10, p987 

    The article presents a randomized clinical trial, Best Adjustment Strategy for Asthma in the Long Term (BASALT) to determine the adjustments of inhaled corticosteroid therapy in preventing treatment failure in adults with mild to moderate asthma. The study concluded that the adults with mild to...

  • Symbicort matches usual care and cuts steroid dose.  // Pulse;11/9/2011, Vol. 71 Issue 37, p8 

    The article reports that Symbicort therapy for asthmatic patients provides similar effects with the guideline-driven care, although it receives lower steroid dose.

  • Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber. Yamamoto, Heizaburo; Yonekura, Syuji; Sakurai, Daiju; Katada, Koji; Inamine, Ayako; Hanazawa, Toyoyuki; Horiguchi, Shigetoshi; Okamoto, Yoshitaka // Allergy & Asthma Proceedings;Sep/Oct2012, Vol. 33 Issue 5, p397 

    Environmental challenge chambers (ECC) have been used to expose people to pollen allergens within a stable atmosphere and to examine the efficacy of treatment. Although pollinosis is one of the typical IgE-mediated type I allergic diseases, allergic inflammation is thought to contribute to the...

  • Validation of the asthma impact survey, a brief asthma-specific quality of life tool. Schatz, Michael; Mosen, David; Kosinski, Mark; Vollmer, William M.; O’Connor, Elizabeth; Cook, E. Francis; Zeiger, Robert S.; O'Connor, Elizabeth // Quality of Life Research;Mar2007, Vol. 16 Issue 2, p345 

    Background: The Asthma Impact Survey (AIS-6) is a new six question asthma outcome tool for which information on validity has not been published.Objective: To provide validation for the AIS-6 as a brief asthma-specific quality of life tool.Methods: Surveys...

  • Using Health Outcomes Data to Inform Decision-Making: Healthcare Payer Perspective. Lancry, P-J.; O'Connor, R.; Stempel, D.; Raz, M. // PharmacoEconomics;Oct2001 Supplement 2, Vol. 19 Issue 10, p39 

    Healthcare payers are charged with the responsibility of achieving maximum profits or output within their limited budget. As the demands are always greater than the budget, there is growing interest in tools that can inform decisions on the allocation of limited resources. Healthcare payers are...

  • Ipratropium Bromide for Acute Asthma Exacerbations. Sadovsky, Richard // American Family Physician;01/15/2000, Vol. 61 Issue 2, p502 

    Focuses on a study by R.G. Stoodley and associates which conducted a meta-analysis of clinical trials in which ipratropium was used as an adjunct to beta2 agonists in the treatment of acute asthma exacerbation in adults. Effect of ipratropium compared with placebo; Effects of combination...

  • Knowing Relapse Risk Factors Can Improve Asthma Treatment. Moore, Amy Slugg // RN;Nov98, Vol. 61 Issue 11, p16 

    Focuses on three risks factors for asthma relapse within eight weeks of ED treatment, which were identified by researchers from the University of Illinois. Details on the three risk factors; Likelihood of relapse when all three risk factors are present; How the discovery of these three risk...


Read the Article


Sign out of this library

Other Topics